| ˹èǧҹ |
»ÃСÒÈ |
»ÃСÒÈàªÔªÇ¹ |
àÍ¡ÊÒÃṺ·éÒ |
ÃÒ¤Ò¡ÅÒ§ |
TOR |
Çѹ»ÃСÒÈ |
¼Ùé¢ÍÃѺ/«×éÍàÍ¡ÊÒà |
¼ÙéÂ×蹫ͧ |
¼ÙéÁռŻÃÐ⪹ìÃèÇÁ¡Ñ¹ |
¼Å¼Ù骹Р|
ÊÑÒ |
¡àÅÔ¡»ÃСÒÈ |
ÃÒÂÅÐàÍÕ´ |
| âçàÃÕ¹ÊÒ¸ÔµÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò »ÃÐÊÒ¹ÁԵà (½èÒ»ÃжÁ) | ºÍÃì´ÍѨ©ÃÔÂÐ ¢¹Ò´äÁè¹éÍ¡ÇèÒ 86 ¹ÔéÇ á¢Ç§¤ÅͧàµÂà˹×Í à¢µÇѲ¹Ò ¡Ãا෾ÁËÒ¹¤Ã ¨Ó¹Ç¹ 30 à¤Ã×èͧ |  [Hits:6] | 1 | 1 | 1 | 1 ¡.¾. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø ªÅ»Ãзҹ ÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò | ªØ´à¤Ã×èͧÁ×ͼèҵѴ·Ò§ÈÑÅ¡ÃÃÁ ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø µÓºÅºÒ§µÅÒ´ ÍÓàÀͻҡà¡Ãç´ ¨Ñ§ËÇÑ´¹¹·ºØÃÕ ¨Ó¹Ç¹ 1 ªØ´
| [Hits:3] | 1 | 1 | 2 | 31 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÊӹѡËÍÊÁØ´¡ÅÒ§ | »ÃСǴÃÒ¤Ò«×éÍÃкºÀÒ¾áÅÐàÊÕ§Ëéͧ»ÃЪØÁ È.´Ã.Êش㨠àËÅèÒÊع·Ã á¢Ç§¤ÅͧàµÂà˹×Í à¢µÇѲ¹Ò ¡Ãا෾ÁËÒ¹¤Ã ¨Ó¹Ç¹ ñ Ãкº ¤ÃÑ駷Õè ò | [Hits:2] | 1 | 1 | 1 | 31 Á.¤. 66 | - | - | - | - | - | - | Detail |
| âçàÃÕ¹ÊÒ¸ÔµÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò »ÃÐÊÒ¹ÁԵà (½èÒ»ÃжÁ) | à¤Ã×èͧµÃǨ¢éÍÊͺ OMR á¢Ç§¤ÅͧàµÂà˹×Í à¢µÇѲ¹Ò ¡Ãا෾ÁËÒ¹¤Ã ¨Ó¹Ç¹ 1 à¤Ã×èͧ | [Hits:10] | 1 | 1 | 1 | 31 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ¤³Ð¾ÂÒºÒÅÈÒʵÃì | ¨éÒ§¡èÍÊÃéÒ§§Ò¹»ÃѺ»Ãاâ¤Ã§ÊÃéҧʶһѵ¡ÃÃÁÈÙ¹Âì¨ÓÅͧʶҹ¡Òóì¡ÒÃÍÀÔºÒÅ·Òáááà¡Ô´ÀÒÇÐÇÔ¡ÄµÔ (NICU) áÅÐÍÀÔºÒżÙé»èÇÂà´ç¡ÇÔ¡ÄµÔ (PICU) µÓºÅͧ¤ÃÑ¡Éì ÍÓàÀÍͧ¤ÃÑ¡Éì ¨Ñ§ËÇÑ´¹¤Ã¹Ò¡ | [Hits:4] | 1 | 5 | 2 | 30 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø ªÅ»Ãзҹ ÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò | ÂÒCalcium carbonate 1.5 g film-coated tablet ¨Ó¹Ç¹ 1,800,000 àÁç´ | [Hits:4] | 1 | 1 | 1 | 30 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø ªÅ»Ãзҹ ÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò | ÂÒbudesonide 160 cmg/1 dose + formoterol fumarate dihydrate 4.5 mcg/
1 dose inhalation powder, 120 dose inhalation ¨Ó¹Ç¹ 1,250 ¢Ç´
| [Hits:1] | 1 | 1 | 1 | 30 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø ªÅ»Ãзҹ ÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò | «×éÍÂÙ¹Ôµ·Ó¿Ñ¹ µÓºÅºÒ§µÅÒ´ ÍÓàÀͻҡà¡Ãç´ ¨Ñ§ËÇÑ´¹¹·ºØÃÕ ¨Ó¹Ç¹ 2 ªØ´ | [Hits:4] | 1 | 1 | 1 | 27 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ºÑ³±ÔµÇÔ·ÂÒÅÑ | »ÃСÒÈ »ÃСǴÃÒ¤Ò«×éÍà¤Ã×èͧà«ÔÃì¿àÇÍÃìÃͧÃѺÃкº§Ò¹ÊÒÃʹà·È¢Í§ºÑ³±ÔµÇÔ·ÂÒÅÑ ¨Ó¹Ç¹ 1 à¤Ã×èͧ ´éÇÂÇÔ¸Õ»ÃСǴÃÒ¤ÒÍÔàÅç¡·Ã͹ԡÊì (e-bidding)
| [Hits:6] | 1 | 1 | 1 | 26 Á.¤. 66 | - | - | - | - | - | - | Detail |
| Êӹѡ¤ÍÁ¾ÔÇàµÍÃì | »ÃСǴÃÒ¤Ò«×éÍÍØ»¡Ã³ì¨Ñ´à¡çº¢éÍÁÙÅÊÓËÃѺÃкºÊÓÃͧ¢éÍÁÙÅ (Storage) ¨Ó¹Ç¹ 1 à¤Ã×èͧ ´éÇÂÇÔ¸Õ»ÃСǴÃÒ¤ÒÍÔàÅç¡·Ã͹ԡÊì (e-bidding) | [Hits:7] | 3 | 1 | 1 | 25 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø ªÅ»Ãзҹ ÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò | ÂÒAmino acid 600 mg film-coated tablet ¨Ó¹Ç¹ 34,000 àÁç´ | [Hits:2] | 1 | 1 | 1 | 24 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ¤³ÐÇѲ¹¸ÃÃÁÊÔè§áÇ´ÅéÍÁáÅСÒ÷èͧà·ÕèÂÇàªÔ§¹ÔàÇÈ | «×éͤÃØÀѳ±ìà¤Ã×èͧÇÔà¤ÃÒÐËìËÒ»ÃÔÁÒ³ÍÔ¹·ÃÕÂì¤ÒÃìºÍ¹ÃÇÁã¹ÊÒÃÅÐÅÒ µÓºÅͧ¤ÃÑ¡Éì ÍÓàÀÍͧ¤ÃÑ¡Éì ¨Ñ§ËÇÑ´¹¤Ã¹Ò¡ ¨Ó¹Ç¹ ñ ªØ´
| [Hits:12] | 1 | 1 | 1 | 24 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø ªÅ»Ãзҹ ÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò | ÂÒCisatracurium Besylate 10 mg/ 5 mL solution for injection/infusion ¨Ó¹Ç¹ 6,500 ¢Ç´
| [Hits:3] | 1 | 1 | 1 | 23 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø ªÅ»Ãзҹ ÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò | ÂÒIspaghula husk 3.5 g granules for oral solution, sachet ¨Ó¹Ç¹ 150,000 «Í§ | [Hits:3] | 1 | 1 | 1 | 23 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø ªÅ»Ãзҹ ÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò | ÂÒlatanoprost 5 mg/100 mL eye drops, solution, 2.5 mL bottle ¨Ó¹Ç¹ 6,500 ¢Ç´ | [Hits:1] | 1 | 1 | 1 | 23 Á.¤. 66 | - | - | - | - | - | - | Detail |
| Êӹѡ¤ÍÁ¾ÔÇàµÍÃì | »ÃСǴÃÒ¤Ò«×éÍÍØ»¡Ã³ì¡ÃШÒÂÊÑÒ³à¤Ã×Í¢èÒ¤ÍÁ¾ÔÇàµÍÃì (Distribution Switch) ¢¹Ò´äÁè¹éÍ¡ÇèÒ 24 Port ¨Ó¹Ç¹ 4 à¤Ã×èͧ | [Hits:8] | 3 | 1 | 1 | 20 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÒÃá¾·Âì»Ñҹѹ·ÀÔ¡¢Ø ªÅ»Ãзҹ ÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò | ªØ´à¤Ã×èͧÁ×ͼèҵѴ¶èÒ§ÊÁͧẺǧáËǹ µÓºÅºÒ§µÅÒ´ ÍÓàÀͻҡà¡Ãç´ ¨Ñ§ËÇÑ´¹¹·ºØÃÕ ¨Ó¹Ç¹ 1 ªØ´ | [Hits:1] | 1 | 1 | 1 | 20 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ÈÙ¹Âì¡ÕÌÒÏ | »ÃСǴÃÒ¤Ò«×éÍ à¤Ã×èͧµÃǨÇÔà¤ÃÒÐËìÊÒêÕÇÀÒ¾ µÓºÅͧ¤ÃÑ¡Éì ÍÓàÀÍͧ¤ÃÑ¡Éì ¨Ñ§ËÇÑ´¹¤Ã¹Ò¡ ¨Ó¹Ç¹ 1 à¤Ã×èͧ | [Hits:3] | 1 | 1 | 1 | 19 Á.¤. 66 | - | - | - | - | - | - | Detail |
| ¤³Ð¾ÅÈÖ¡ÉÒ | ¨Ñ´«×éͤÃØÀѳ±ì»ÃСͺÈÙ¹ÂìÍÍ¡¡ÓÅѧ¡Ò ÁÈÇ Í§¤ÃÑ¡Éì µÓºÅͧ¤ÃÑ¡Éì ÍÓàÀÍͧ¤ÃÑ¡Éì ¨Ñ§ËÇÑ´¹¤Ã¹Ò¡ ¨Ó¹Ç¹ 1 ªØ´ | [Hits:5] | 1 | 1 | 1 | 19 Á.¤. 66 | - | - | - | - | - | - | Detail |
| âçàÃÕ¹ÊÒ¸ÔµÁËÒÇÔ·ÂÒÅÑÂÈÃÕ¹¤ÃÔ¹·ÃÇÔâò »ÃÐÊÒ¹ÁԵà (½èÒ»ÃжÁ) | à¤Ã×èͧµÃǨ¢éÍÊͺ OMR á¢Ç§¤ÅͧàµÂà˹×Í à¢µÇѲ¹Ò ¡Ãا෾ÁËÒ¹¤Ã ¨Ó¹Ç¹ 1 à¤Ã×èͧ | [Hits:2] | 1 | 1 | 1 | 17 Á.¤. 66 | - | - | - | - | - | - | Detail |
| Êèǹ¾Ñ²¹Ò¡ÒÂÀÒ¾ | «×é;ѴÅÁäÍàÂç¹ ¢¹Ò´¤ÇÒÁ¨Ø 93 ÅԵà á¢Ç§¤ÅͧàµÂà˹×Í à¢µÇѲ¹Ò ¡Ãا෾ÁËÒ¹¤Ã ¨Ó¹Ç¹ 20 à¤Ã×èͧ | [Hits:7] | 1 | 1 | 1 | 4 Á.¤. 66 | - | - | - | | - | - | Detail |
| ÊӹѡËÍÊÁØ´¡ÅÒ§ | »ÃСǴÃÒ¤Ò«×éÍà¤Ã×èͧ¿Í¡ÍÒ¡ÒÈ áºº½Ñ§ãµéྴҹ ËÃ×ÍẺµÔ´¼¹Ñ§ ËÃ×ÍẺà¤Å×è͹ÂéÒ ¢¹Ò´¤ÇÒÁàÃçǢͧáçÅÁÃдѺÊÙ§äÁèµèÓ¡ÇèÒ ñ,ððð «ÕàÍ¿àÍçÁ á¢Ç§¤ÅͧàµÂà˹×Í à¢µÇѲ¹Ò ¡Ãا෾ÁËÒ¹¤Ã ¨Ó¹Ç¹ õð à¤Ã×èͧ | [Hits:12] | 1 | 1 | 1 | 26 ¸.¤. 65 | - | - | - | | - | - | Detail |
